Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2010
10/05/2010US7807876 Antimicrobial peptides and methods of use
10/05/2010US7807822 Purification of plasmid nucleotide sequences from bacterial cells; obtain cells, lyse, precipatate, centrifuge precipitate mixture, expose to ion exchange column, recover nucleotide sequences
10/05/2010US7807821 Method for the synthesis of nucleic acid without protecting base moiety
10/05/2010US7807820 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing
10/05/2010US7807819 siRNA targeting survivin
10/05/2010US7807818 Reverse-sense nucleotide sequences for use in treatment of ulcerative colitis, crohn's and/or inflammatory bowel disease
10/05/2010US7807817 Catalytic DNA molecule having site-specific endonuclease activity which cleaves RNA in site specific manner; enzyme engineering technology and directed protein evolution
10/05/2010US7807816 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
10/05/2010US7807815 nucleic acid-lipid particles comprising short intefering sequences with mismatch motif, and 1,2-DiLinoleyloxy-N,N-dimethylaminopropane (DLinDMA) or 1,2-Dilinolenyloxy-N,N-dimethylaminopropane (DLenDMA), for use in silencing target gene sequences
10/05/2010US7807814 Compositions and methods for combined therapy of disease
10/05/2010US7807813 Kit comprising amplification primers and an internal control sequence for use in detection of west nile viral genomes; assuring safety of blood supply
10/05/2010US7807810 Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
10/05/2010US7807809 Molecular characterization of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis
10/05/2010US7807808 Bacteria with increased levels of protein secretion, nucleotide sequences coding for a SecA protein with increased levels of protein secretion, and method for producing proteins
10/05/2010US7807807 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
10/05/2010US7807806 Composition comprising nucleic acid which forms cleavable nucleic acid structure on specific target sequences in a site-specific manner
10/05/2010US7807805 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
10/05/2010US7807803 For prophylaxis and therapy of infectious disease, allergy, cancer
10/05/2010US7807802 Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
10/05/2010US7807801 Method of inhibition of flavivirus to prevent and cure viral diseases by administering nucleotides
10/05/2010US7807653 Nucleotide mimics and their prodrugs
10/05/2010US7807652 Antisense agents for use in treatment of diabetes and controlling blood lipid levels; gene expression inhibition; genes involved in glucose metabolism are glucose-6-phosphatase and glycogen synthase;steatohepatitis; decreasing hepatic triglyceride levels
10/05/2010US7807650 such as IBD and Crohn's disease; intrarectal administration of siNA compounds
10/05/2010US7807648 G-rich polynucleotides for the treatment of Huntington's Disease
10/05/2010US7807465 Methods for identifying an individual at increased risk of developing coronary artery disease
10/05/2010US7807460 Plasmid regulated by heat-shock sigma factor for use as gene transfer tool in genetic engineering; improved/enhanced exogenous transcription
10/05/2010US7807455 Generating viral replicon having an increased replication activity in a Huh7 cells using variant viral coding sequences; prevention and treatment of liver inflammation, infection and failure
10/05/2010US7807447 Compositions and methods for exon profiling
10/05/2010US7807443 Microorganisms providing novel gene products forming or decomposing polyamino acids
10/05/2010US7807442 PUFA polyketide synthase systems and uses thereof
10/05/2010US7807438 Vessicular composition comprising hepatitis C virus RNA sequences for use in designing drugs for treatment and prevention of viral infection
10/05/2010US7807436 Recombinant host for producing L-asparaginase II
10/05/2010US7807434 Detergent composition comprising enhanced glucanase for use in textile treatment and enhancing cleaning performance
10/05/2010US7807433 Heat resistant hydrolase for use in food processing, pharmaceuticals, textile treatment, detergent and baking industries
10/05/2010US7807430 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening
10/05/2010US7807422 Production of flavonoids by recombinant microorganisms
10/05/2010US7807421 Process for production of biopterin compound
10/05/2010US7807418 Method for producing hybrid polyketide synthases
10/05/2010US7807417 Ecdysone receptor-based inducible gene expression system
10/05/2010US7807406 Fagopyritol synthase genes and uses thereof
10/05/2010US7807404 Mutated truncated mt-pfkA gene for the synthesis of active shorter fragment of 6-phosphofructo-1-kinase
10/05/2010US7807390 G-protein coupled receptor ligands and methods
10/05/2010US7807376 polynucleotide primers comprising modified pyrimidine nucleobases, used for reducing the formation of primer-dimers during amplification reactions; ligation, immobilization
10/05/2010US7807372 efficient method of screening libraries of molecules for DNA selectivity using a gold nanoparticle based colorimetric assay
10/05/2010US7807370 Methods for identification of merle gene
10/05/2010US7807366 Genetic markers for assessing risk of premature birth resulting from preterm premature rupture of membranes
10/05/2010US7807365 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment
10/05/2010US7807364 determining whether a patient will respond to anti-VEGF antibody based chemotherapy by screening suitable cell or tissue sample from the patient for at least one genomic polymorphism or genotype; using a bevacizumab antibody or an antibody that binds to the same epitope on VEGF and and cyclophosphamide
10/05/2010US7807363 Measuring the expression level of a gene which comprises a nucleotide sequence homologous to the sequence of SEQ ID NO:1;diagnosing or monitoring elevated intraocular pressure or glaucoma
10/05/2010US7807361 Dairy cattle breeding for improved milk production traits in cattle
10/05/2010US7807358 High-throughput methods for detecting DNA methylation
10/05/2010US7807357 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering
10/05/2010US7807354 Low volume hybridization
10/05/2010US7807353 hypoxanthine-guanine phosphoribosyltransferase gene; measuring a difference in levels of expression of a desired gene in two or more kinds of test samples
10/05/2010US7807352 Using microarray comprising immobolized biopolymers which utilizes universal detection elements as tool for identifying preferential compounds
10/05/2010US7807350 Methods for predicting irinotecan toxicity
10/05/2010US7807180 inducing an immune response to a poxvirus in a mammal by administering a composition comprising a nucleic acid molecule comprising nucleotide sequence encoding a variola F8 polypeptide, wherein nucleotide sequence is codon optimized for expression in both a mammalian cell and a bacterial cell
10/05/2010US7807176 Polypeptide promoting vascular endothelial cell growth
10/05/2010US7807174 Class of therapeutic protein based molecules
10/05/2010CA2393479C Process for the scaleable purification of plasmid dna
09/2010
09/30/2010WO2010111674A2 Methods and apparatus for single molecule sequencing using energy transfer detection
09/30/2010WO2010111587A1 Modulators of tdp-43 mediated toxicity
09/30/2010WO2010111503A2 RNA INTERFERENCE MEDIATED INHIBITION OF THE HIGH AFFINITY IGE RECEPTOR ALPHA CHAIN (FCεRLα) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
09/30/2010WO2010111494A1 Single molecule sensitive probes for detecting rna
09/30/2010WO2010111466A1 Aptamer-mediated drug release
09/30/2010WO2010111464A1 RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/30/2010WO2010111206A1 Methods of producing c4 dicarboxcylic acids
09/30/2010WO2010110775A1 Reagents for reversibly terminating primer extension
09/30/2010WO2010109268A1 Synthesis of oligonucleotide mediated gold core- silver shell nanoparticles
09/30/2010WO2010108325A1 Loop-shaped primer employed in nucleic acid amplification and the use thereof
09/30/2010WO2010108275A1 Method and apparatus for predicting susceptibility to a developmental disorder
09/30/2010WO2010091396A3 Aptamers to von willerbrand factor and their use as thrombotic, hematologic and cardiovascular disease therapeutics
09/30/2010WO2010091308A3 Oligomeric compounds and methods
09/30/2010WO2010090969A4 Tetrahydropyran nucleic acid analogs
09/30/2010WO2006050499A3 Single step detection assay
09/30/2010US20100251432 Novel Herbicide Resistance Genes
09/30/2010US20100251430 Highly Infectious Nucleic Acid Molecules from Pepper Mottle Virus and Plant Viral Vector Derived from the Same
09/30/2010US20100251429 Novel protein, a gene encoding therefor and a method of using the same
09/30/2010US20100251426 Extra-Cellular Matrix Localized Ferritin for Iron Uptake, Storage, and Stress Tolerance
09/30/2010US20100251422 Application of ERF genes from Bupleurum kaoi
09/30/2010US20100251420 Generation of plants with altered protein, fiber, or oil content
09/30/2010US20100251419 Novel nucleic acids from sesame plants
09/30/2010US20100251416 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production
09/30/2010US20100249386 Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (dnp)
09/30/2010US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide
09/30/2010US20100249372 Botulinum neurotoxin a receptor and the use thereof
09/30/2010US20100249220 Coumermycin/novobicin-regulated gene expression system
09/30/2010US20100249219 Short rna antagonist compounds for the modulation of hif-1alpha
09/30/2010US20100249218 Method to inhibit cell growth using oligonucleotides
09/30/2010US20100249216 Method for the production of a cell and/or tissue and/or disease phase specific medicament
09/30/2010US20100249215 Oligomeric Compounds And Compositions For Use In Modulation Of Pri-miRNAs
09/30/2010US20100249213 MicroRNA Signatures in Human Ovarian Cancer
09/30/2010US20100249212 Gene Silencing Using mRNA-cDNA Hybrids
09/30/2010US20100249211 N-Substituted-Aminomethylene Bridged Bicyclic Nucleic Acid Analogs
09/30/2010US20100249210 Methods and compositions related to dlk-1 and the p38 mapk pathway in nerve regeneration
09/30/2010US20100249209 Gene involved in immortalization of human cancer cell and use thereof
09/30/2010US20100249175 Dicationic compounds which selectively recognize G-quadruplex DNA
09/30/2010US20100249052 Dsrna compositions and methods for treating hpv infections
09/30/2010US20100249038 Antagonists of the receptor for advanced glycation end-products (rage)
09/30/2010US20100249035 Peptides, compositions and uses thereof